Skip to main content

Table 2 Incidence of active CMV infection

From: Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation

Patients n = 63
Positive N-PCR and/or AGM, n (%) 49 (78%)
Median time, days (range) 38 (1–150)
Positive N-PCR, n (%) 49 (78%)
Median time, days (range) 34 (1–140)
Positive AGM, n (%) 37 (58.7%)
Median time, days (range) 46 (14–150)
  1. N-PCR nested polymerase chain reaction, AGM antigenemia.